Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05776862 · ClinicalTrials.gov registry record · Phase 2
Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)
A Phase 2 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT05776862 is a Phase 2 study that has completed, run by University of Miami. The registered enrollment target is 10 participants.
The verdict
NCT05776862, a Phase 2 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study will evaluate if Ursolic Acid supplementation may be effective in reducing muscle loss and improving blood sugar control in the SCI community.
Interventions
- OTHER Strength Training
- DRUG Ursolic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-03-27 |
| Est. Completion | 2025-01-29 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05776862
The ClinicalTrials.gov registry entry for NCT05776862 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Strength Training is the first listed.
NCT05776862 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05776862 about?
NCT05776862 is a clinical study titled "Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)". This study will evaluate if Ursolic Acid supplementation may be effective in reducing muscle loss and improving blood sugar control in the SCI community.
What is the current status of trial NCT05776862?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2023-03-27. Estimated completion is 2025-01-29.
What interventions are being tested in trial NCT05776862?
The interventions under investigation include: Strength Training (OTHER), Ursolic Acid (DRUG).
Who is sponsoring clinical trial NCT05776862?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.